Suivre
Prisni Rath
Titre
Citée par
Citée par
Année
Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial
S Lheureux, MC Cristea, JP Bruce, S Garg, M Cabanero, ...
The Lancet 397 (10271), 281-292, 2021
1452021
EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay
S Volpi, Y Yamazaki, PM Brauer, E van Rooijen, A Hayashida, ...
Journal of Experimental Medicine 214 (3), 623-637, 2017
812017
Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genes
R Muff, P Rath, RM Ram Kumar, K Husmann, W Born, M Baudis, B Fuchs
PloS one 10 (5), e0125611, 2015
532015
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
DL Clouthier, SC Lien, SYC Yang, LT Nguyen, VSK Manem, D Gray, ...
Journal for immunotherapy of cancer 7, 1-12, 2019
472019
Progenetix: 12 years of oncogenomic data curation
H Cai, N Kumar, N Ai, S Gupta, P Rath, M Baudis
Nucleic acids research 42 (D1), D1055-D1062, 2014
432014
Epigenomic, genomic, and transcriptomic landscape of schwannomatosis
S Mansouri, S Suppiah, Y Mamatjan, I Paganini, JC Liu, S Karimi, V Patil, ...
Acta neuropathologica 141, 101-116, 2021
282021
Minimalist approaches to cancer tissue-of-origin classification by DNA methylation
D Xia, AJ Leon, M Cabanero, TJ Pugh, MS Tsao, P Rath, LLY Siu, C Yu, ...
Modern Pathology 33 (10), 1874-1888, 2020
232020
arrayMap 2014: an updated cancer genome resource
H Cai, S Gupta, P Rath, N Ai, M Baudis
Nucleic acids research 43 (D1), D825-D830, 2015
192015
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first‐line platinum chemotherapy in high grade serous ovarian cancer
JI Weberpals, TJ Pugh, P Marco‐Casanova, GD Goss, N Andrews Wright, ...
Cancer Medicine 10 (9), 3045-3058, 2021
102021
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities
S Suppiah, S Mansouri, Y Mamatjan, JC Liu, MM Bhunia, V Patil, P Rath, ...
Nature communications 14 (1), 2696, 2023
62023
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer
A Madariaga, S Garg, JP Bruce, S Thiryayi, V Mandilaras, P Rath, AM Oza, ...
Gynecologic Oncology 159 (2), 539-545, 2020
42020
Tumor molecular profiling to differentiate extreme responses to first-line platinum-based chemotherapy in suboptimally debulked serous ovarian cancer patients.
JI Weberpals, T Pugh, GD Goss, B Lo, N Andrews Wright, L Bernard, ...
Journal of Clinical Oncology 36 (15_suppl), 5561-5561, 2018
22018
Epigenomic, genomic, and transcriptomic landscape of schwannomatosis (October, 10.1007/s00401-020-02230-x, 2020)
S Mansouri, S Suppiah, Y Mamatjan, I Paganini, JC Liu, S Karimi, V Patil, ...
ACTA NEUROPATHOLOGICA 141 (1), 117-117, 2021
2021
Gemcitabine plus adavosertib for platinum-resistant/refractory recurrent ovarian cancer: A randomised placebo-controlled trial
S Lheureux, MC Cristea, JP Bruce, S Garg, M Cabanero, ...
Lancet (London, England) 397 (10271), 281, 2021
2021
Mt Receptor
D Actinomycin, S Lheureux, MC Cristea, JP Bruce, S Garg, M Cabanero, ...
Lancet 397, 281-92, 2021
2021
EPCO-04. GENOMIC AND EPIGENOMIC HALLMARKS OF SCHWANNOMATOSIS SCHWANNOMAS
S Mansouri, S Suppiah, Y Mamatjan, I Paganini, J Liu, S Karimi, V Patil, ...
Neuro-Oncology 22 (Suppl 2), ii69, 2020
2020
Biomarkers of outcome with weekly paclitaxel in platinum-resistant high-grade serous or endometrioid ovarian carcinoma
A Madariaga, S Garg, J Bruce, P Rath, V Mandilaras, S Thiryayi, AM Oza, ...
Gynecologic Oncology 159, 149, 2020
2020
13. Bioinformatics and interpretation for clinical reporting of an integrated whole genome and transcriptome assay
A Fortuna, P Rath, A Leon, X Luo, Y Sundaravadanam, P Ruzanov, ...
Cancer Genetics 244, 5-6, 2020
2020
Cc 5013 is a more potent molecular analog of thalidomide. Menu
S Lheureux, MC Cristea, JP Bruce, S Garg, M Cabanero, ...
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–19